Loading, please wait...
| Microsoft Teams meeting | |||||
| Join: https://teams.microsoft.com/meet/27831647512726?p=NbP0vM20llCKNRsAHk | |||||
| Meeting ID: 278 316 475 127 26 | |||||
| Passcode: YT9bm9Pq | |||||
Date: Mar 26, 2026 06:45 AM - 07:45 AM
Fee
$0.00
CE Hours
2.00
CE Units
0.200
Registration closes on Apr 02, 2026 11:00 PM
Activity Type
- Application
Target Audience(s)
- Pharmacists
- Pharmacy Technicians
Accreditation(s)
|
WellStar Health System is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
|
Requirements for CE Credit
Participants who attend the entire activity, complete and pass the post-test (>70%) and complete the activity evaluation will receive CE credit.
Credit will be uploaded electronically and be available in CPE Monitor after completion of required elements.
Support/Credits
No commerical support.
Thu, Mar 26, 2026
Thu, Mar 26, 2026
| Microsoft Teams meeting | |||||
| Join: https://teams.microsoft.com/meet/27831647512726?p=NbP0vM20llCKNRsAHk | |||||
| Meeting ID: 278 316 475 127 26 | |||||
| Passcode: YT9bm9Pq | |||||
Objectives
- Identify buprenorphine formulations and routes of administration. .
- Describe proper administration techniques and patient counseling points, including dental risk reduction.
- Process and prepare buprenorphine orders accurately in collaboration with pharmacists and nursing staff.
Speaker(s)/Author(s)
|
Alyan Saeed, PharmD
|
Activity Number
0483-0000-26-001-L08-T
Date:
03/26/26
Time:
06:45 AM - 07:45 AM
CE Hours
1.00
Location
via MS Teams and KH
| Microsoft Teams meeting | |||||
| Join: https://teams.microsoft.com/meet/27831647512726?p=NbP0vM20llCKNRsAHk | |||||
| Meeting ID: 278 316 475 127 26 | |||||
| Passcode: YT9bm9Pq | |||||
Objectives
- Describe buprenorphine's receptor activity and implications for analgesia.
- Apply evidence-based strategies for acute pain management in patients receiving buprenorphine.
- Assess patient appropriateness for buprenorphine therapy based on pain type, comorbidities, and concurrent medications.
Speaker(s)/Author(s)
|
Alyan Saeed, PharmD
|
Activity Number
0483-0000-26-001-L08-P
Date:
03/26/26
Time:
06:45 AM - 07:45 AM
CE Hours
1.00
Location
via MS Teams and KH